Hologic Granted FDA Emergency Use Authorization for Asymptomatic COVID-19 Testing with Panther Fusion SARS-CoV-2 AssayBusiness Wire • 09/28/20
Hologic Announces Pricing of Offering of $950 Million of 3.250% Senior Notes Due 2029Business Wire • 09/14/20
Hologic's stock soars after revenue outlook raised well above analyst expectationsMarket Watch • 09/11/20
Hologic to Acquire Acessa Health, Innovator in Minimally Invasive Solutions for Treatment of FibroidsBusiness Wire • 08/25/20
8 Earnings Winners Seeing Major Analyst Upgrades for Even More Upside Ahead24/7 Wall Street • 07/30/20
Hologic, Inc. (HOLX) CEO Steve MacMillan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/30/20